About epirubicin hcl
Anthracycline chemotherapy medicine
Used for
- Treats breast cancer and other cancers, often as part of combination chemotherapy.
Usual adult dose
Varies by cancer and regimen; given intravenously in cycles, commonly 60–100 mg/m² per cycle.
Common side effects
- Low blood cell counts and infection risk
- Nausea, vomiting, mouth sores, hair loss
- Heart damage, which may be delayed
- Red urine for a short time after treatment
Important warnings
- Only trained cancer specialists should give this medicine.
- Heart function and blood counts require monitoring.
- Avoid accidental skin contact; tissue damage can occur if it leaks from a vein.
- It can harm an unborn baby and may affect fertility.
Pregnancy
Can cause fetal harm. Avoid during pregnancy unless a specialist determines treatment is essential.
Breastfeeding
Breastfeeding is not recommended during treatment and for at least seven days after the last dose.
Interactions
- Other medicines that can damage the heart may increase heart risks.
- Other chemotherapy or radiation can increase bone marrow suppression.
- Strong CYP3A4 inhibitors or inducers may alter epirubicin exposure.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.